• In early February 2026, Reinsurance Group of America, Incorporated reported higher fourth-quarter and full-year 2025 revenue and net income, declared a regular US$0.93 per-share quarterly dividend, and outlined recent buybacks totaling US$125 million.
• On the same day, the company also authorized a new share repurchase program of up to US$500 million, signaling an increased focus on returning capital to shareholders alongside earnings growth.
• Next, we’ll examine how the stronger quarterly earnings and expanded US$500 million repurchase authorization affect Reinsurance Group of America’s investment narrative.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Reinsurance Group of America Investment Narrative Recap

To own Reinsurance Group of America, you need to believe its global life and health reinsurance franchise can convert disciplined underwriting, capital strength, and data-driven solutions into relatively steady earnings, despite inherent claims volatility. The latest Q4 and full-year 2025 results, with higher revenue and net income, modestly support this case in the near term, while the biggest ongoing risk remains that swings in U.S. individual life and healthcare excess claims could quickly reintroduce earnings variability.

The new US$500 million share repurchase authorization is the most relevant element here, because it sits alongside solid 2025 earnings and an ongoing US$0.93 quarterly dividend. Together, these moves highlight that management currently has sufficient confidence in RGA’s capital position to keep returning cash to shareholders, even as the company continues to manage claims volatility, rising healthcare costs, and region-specific regulatory risks that could influence how much capital is available for future buybacks.

But against this, investors should also be aware that persistent volatility in U.S. individual life claims could still...

Reinsurance Group of America's narrative projects $29.2 billion revenue and $1.9 billion earnings by 2028. This requires 10.3% yearly revenue growth and a $1.1 billion earnings increase from $770.0 million today.

Uncover how Reinsurance Group of America's forecasts yield a $236.89 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Some of the most pessimistic analysts were assuming RGA would reach about US$27.6 billion in revenue and US$2.0 billion in earnings by 2028, yet still face pressure from rising healthcare excess claims costs, showing how differently you might weigh this latest earnings and buyback news compared with those lower expectations.

Explore 3 other fair value estimates on Reinsurance Group of America - why the stock might be worth over 3x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Reinsurance Group of America research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Reinsurance Group of America research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Reinsurance Group of America's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
• Uncover the next big thing with 31 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.